Alessandro Tomelleri

42PUBLICATIONS
185CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingCardiology (incl. cardiovascular diseases)Venereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 07, 2026
MEK inhibition achieves robust and durable responses in Erdheim-Chester disease.

|Sep 28, 2026
Comparative Effectiveness of Tocilizumab and Tumor Necrosis Factor Inhibitors in Takayasu Arteritis: Age-Related Differences in Treatment Response.

|Sep 21, 2026
Real-World Effectiveness and Safety of Secukinumab in Giant Cell Arteritis: An Italian Multicenter Cohort Study.

|Mar 20, 2026
Management of Takayasu Arteritis - A 2026 Update.

Tanaz A Kermani, Alessandro Tomelleri, Daniele Scaramuzzi

|Sep 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study.

Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro

|Aug 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.

Arsene Mekinian, Sophie Georgin-Lavialle, Marcela A Ferrada

Pageof 7

Frequent Collaborators

28 joint publications

Corrado Campochiaro

14 joint publications

Lorenzo Dagna

6 joint publications

Sara Monti

5 joint publications

Nicola Farina